Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

Sponsor

IDinsight (Other)

Overall Status

Completed

CT.gov ID

NCT04013516

Collaborator

GiveWell (Other)

1,088

Enrollment

Location

Arms

Actual Duration (Months)

271.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

IDinsight is conducting a randomized controlled trial to assess the impact of various sized cash incentives for caretakers of infants that require a 9-month measles vaccination on the completion rate for the vaccine in Nigeria. The purpose of the experiment is to help New Incentives (NI) determine the optimal size of the incentive as they scale to the North West region of Nigeria.

Condition or Disease	Intervention/Treatment	Phase
Measles	Behavioral: Cash Incentive Behavioral: Call	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

1088 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Intervention Model Description:

Participants randomly assigned to different incentive amounts (treatment arms), a pure control arm, and a placebo arm which consisted of a phone call without an additional incentive.Participants randomly assigned to different incentive amounts (treatment arms), a pure control arm, and a placebo arm which consisted of a phone call without an additional incentive.

Masking:

None (Open Label)

Primary Purpose:

Other

Official Title:

Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

Actual Study Start Date :

May 12, 2017

Actual Primary Completion Date :

Sep 11, 2017

Actual Study Completion Date :

Sep 11, 2017

Arms and Interventions

Arm	Intervention/Treatment
No Intervention: Pure Control Respondents received New Incentives' normal program.
Placebo Comparator: Reminder Call Respondents received a call from a New Incentives' staff member similar to the treatment arms, but weren't offered additional incentives.	Behavioral: Call A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).
Experimental: Small Additional Incentive Respondents were told they would receive 1000 NGN more than originally promised by New Incentives' (either 2000 or 3000 NGN) when they brought their child for measles immunization.	Behavioral: Cash Incentive During the phone call, New Incentives' team member promised a greater cash payment from New Incentives' staff members at primary health care facilities when infants enrolled in the program and received their measles vaccination. Behavioral: Call A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).
Experimental: Large Additional Incentive Respondents were told they would receive 3000 NGN more than originally promised by New Incentives' (either 2000 or 3000 NGN) when they brought their child for measles immunization.	Behavioral: Cash Incentive During the phone call, New Incentives' team member promised a greater cash payment from New Incentives' staff members at primary health care facilities when infants enrolled in the program and received their measles vaccination. Behavioral: Call A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).

Outcome Measures

Primary Outcome Measures

Measles Vaccination Coverage Rate [We assessed whether eligible infants received measles vaccination at any time during the 4 month study period. Children were a minimum of 9 months at the beginning of the study and a maximum of 7 years at the end of the study.]
The outcome of interest is the measles coverage rate among the eligible randomized infants. Coverage is measured using the measles vaccination information recorded on the child's health card. The child health card information was immediately entered into the New Incentives' database by their field staff when they disbursed the cash incentives at program clinics. Information from the New Incentives' database was used for the analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:

9 Months and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Caregiver and infant registered with the New Incentives program
The infant was nine months or older at the start of the study (note there was no upper age limit as New Incentives only began enrolling infants in October 2016)
Infant had received at least one previous conditional cash transfer for immunization at an All Babies are Equal Initiative clinic,
Infant had received their Penta-3 vaccine.
The caregiver had provided a phone number (either a personal number or a number of someone who can reach them) during registration.

Exclusion Criteria:

Infant had already received a measles vaccine

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	All Babies are Equal Initiative (New Incentives)	Abuja	Federal Capital Territory	Nigeria

Sponsors and Collaborators

IDinsight
GiveWell

Investigators

Principal Investigator: Alison Connor, IDinsight

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

IDinsight

ClinicalTrials.gov Identifier:

NCT04013516

Other Study ID Numbers:

First Posted:

Jul 9, 2019

Last Update Posted:

Jul 9, 2019

Last Verified:

Jul 1, 2019

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by IDinsight

Immunization

Incentives

Additional relevant MeSH terms:

Measles

Study Results

No Results Posted as of Jul 9, 2019